Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bio Essence (BIOE) Short-Term Debt repayments (2023 - 2025)

Bio Essence has reported Short-Term Debt repayments over the past 3 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Short-Term Debt repayments rose 841.86% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $100000.0, changed N/A, while the annual FY2025 figure was $100000.0, 116.6% up from the prior year.
  • Short-Term Debt repayments for Q4 2025 was $1.0 million at Bio Essence, up from -$375000.0 in the prior quarter.
  • Over five years, Short-Term Debt repayments peaked at $1.0 million in Q4 2025 and troughed at -$375000.0 in Q3 2025.
  • A 3-year average of $44116.7 and a median of -$194250.0 in 2024 define the central range for Short-Term Debt repayments.
  • Biggest five-year swings in Short-Term Debt repayments: plummeted 146.07% in 2024 and later surged 841.86% in 2025.
  • Year by year, Short-Term Debt repayments stood at $305400.0 in 2023, then plummeted by 146.07% to -$140700.0 in 2024, then surged by 841.86% to $1.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for BIOE at $1.0 million in Q4 2025, -$375000.0 in Q3 2025, and -$247800.0 in Q2 2025.